144 related articles for article (PubMed ID: 33275775)
21. The prevalence and risk factors for
Ijasan O; Okunade KS; Oluwole AA
Niger Postgrad Med J; 2018; 25(1):21-26. PubMed ID: 29676341
[TBL] [Abstract][Full Text] [Related]
22. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
Subtil D; Brabant G; Tilloy E; Devos P; Canis F; Fruchart A; Bissinger MC; Dugimont JC; Nolf C; Hacot C; Gautier S; Chantrel J; Jousse M; Desseauve D; Plennevaux JL; Delaeter C; Deghilage S; Personne A; Joyez E; Guinard E; Kipnis E; Faure K; Grandbastien B; Ancel PY; Goffinet F; Dessein R
Lancet; 2018 Nov; 392(10160):2171-2179. PubMed ID: 30322724
[TBL] [Abstract][Full Text] [Related]
23. Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol.
Jao J; Kacanek D; Williams PL; Geffner ME; Livingston EG; Sperling RS; Patel K; Bardeguez AD; Burchett SK; Chakhtoura N; Scott GB; Van Dyke RB; Abrams EJ; ;
Clin Infect Dis; 2017 Sep; 65(6):982-989. PubMed ID: 28575201
[TBL] [Abstract][Full Text] [Related]
24. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy outcomes and risk factors for low birth weight and preterm delivery among HIV-infected pregnant women in Guangxi, China.
Yu L; Li WY; Chen RY; Tang ZR; Pang J; Gui XZ; Meng XN; Zhang FJ
Chin Med J (Engl); 2012 Feb; 125(3):403-9. PubMed ID: 22490393
[TBL] [Abstract][Full Text] [Related]
26. Micronutrient supplementation in children and adults with HIV infection.
Irlam JH; Visser MM; Rollins NN; Siegfried N
Cochrane Database Syst Rev; 2010 Dec; (12):CD003650. PubMed ID: 21154354
[TBL] [Abstract][Full Text] [Related]
27. Mefloquine for preventing malaria in pregnant women.
González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
[TBL] [Abstract][Full Text] [Related]
28. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.
González R; Desai M; Macete E; Ouma P; Kakolwa MA; Abdulla S; Aponte JJ; Bulo H; Kabanywanyi AM; Katana A; Maculuve S; Mayor A; Nhacolo A; Otieno K; Pahlavan G; Rupérez M; Sevene E; Slutsker L; Vala A; Williamsom J; Menéndez C
PLoS Med; 2014 Sep; 11(9):e1001735. PubMed ID: 25247995
[TBL] [Abstract][Full Text] [Related]
29. Association between maternal serum homocysteine concentrations in early pregnancy and adverse pregnancy outcomes.
Nwogu CM; Okunade KS; Adenekan MA; Sekumade AI; John-Olabode S; Oluwole AA
Ann Afr Med; 2020; 19(2):113-118. PubMed ID: 32499467
[TBL] [Abstract][Full Text] [Related]
30. Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial.
Price JT; Vwalika B; Freeman BL; Cole SR; Mulenga HB; Winston J; Mbewe FM; Chomba E; Mofenson LM; Rouse DJ; Goldenberg RL; Stringer JSA
BMC Pregnancy Childbirth; 2019 Feb; 19(1):81. PubMed ID: 30813934
[TBL] [Abstract][Full Text] [Related]
31. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
Walter J; Mwiya M; Scott N; Kasonde P; Sinkala M; Kankasa C; Kauchali S; Aldrovandi GM; Thea DM; Kuhn L
J Infect Dis; 2006 Dec; 194(11):1510-8. PubMed ID: 17083035
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D3 supplementation during pregnancy and lactation for women living with HIV in Tanzania: A randomized controlled trial.
Sudfeld CR; Manji KP; Muhihi A; Duggan CP; Aboud S; Alwy Al-Beity FM; Wang M; Zhang N; Ulenga N; Fawzi WW
PLoS Med; 2022 Apr; 19(4):e1003973. PubMed ID: 35427363
[TBL] [Abstract][Full Text] [Related]
33. Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
Nachega JB; Uthman OA; Mofenson LM; Anderson JR; Kanters S; Renaud F; Ford N; Essajee S; Doherty MC; Mills EJ
J Acquir Immune Defic Syndr; 2017 Sep; 76(1):1-12. PubMed ID: 28291053
[TBL] [Abstract][Full Text] [Related]
34. Incidence of and socio-biologic risk factors for spontaneous preterm birth in HIV positive Nigerian women.
Ezechi OC; David AN; Gab-Okafor CV; Ohwodo H; Oladele DA; Kalejaiye OO; Ezeobi PM; Gbajabiamila TA; Adu RA; Oke B; Musa ZA; Ekama SO; Ilesanmi O; Odubela O; Somefun EO; Herbertson EC; Onwujekwe DI; Ujah IA
BMC Pregnancy Childbirth; 2012 Sep; 12():93. PubMed ID: 22958756
[TBL] [Abstract][Full Text] [Related]
35. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study.
Delicio AM; Lajos GJ; Amaral E; Cavichiolli F; Polydoro M; Milanez H
Reprod Health; 2018 May; 15(1):76. PubMed ID: 29747664
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group.
Coutsoudis A; Pillay K; Spooner E; Kuhn L; Coovadia HM
AIDS; 1999 Aug; 13(12):1517-24. PubMed ID: 10465076
[TBL] [Abstract][Full Text] [Related]
37. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.
Hofmeyr GJ; Manyame S
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011192. PubMed ID: 28949421
[TBL] [Abstract][Full Text] [Related]
38. HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
Benhammou V; Tubiana R; Matheron S; Sellier P; Mandelbrot L; Chenadec JL; Marel E; Khoshnood B; Warszawski J;
J Acquir Immune Defic Syndr; 2018 Apr; 77(5):439-450. PubMed ID: 29287028
[TBL] [Abstract][Full Text] [Related]
39. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence and associated risk factors on preterm birth, low birth weight, and small for gestational age among HIV-infected pregnant women in Hunan province, 2011-2017].
Li HX; Zheng JF; Huang GW; Xiao J; Wang H; Yang M; Feng N
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Oct; 39(10):1368-1374. PubMed ID: 30453439
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
